Ennov RIM platform implemented at Boehringer Ingelheim

September 30, 2021

Ennov’s strategic customer Boehringer Ingelheim selected the Ennov RIM as a global Regulatory Information Management (RIM) system for their Animal Health and Human Health businesses. The first major milestone was reached – the platform went live in Animal Health. Ennov and Boehringer Ingelheim will continue to work on the implementation of the platform in Human Health and IDMP reporting.

“We are extremely pleased and would like to congratulate BI Animal Health to their Go-live on our Ennov RIM platform. This achievement is a direct result of the hard work and dedication that our and BI’s teams have demonstrated throughout the project.”

says Olivier Paris, CEO of Ennov.

Ennov continuously drives the evolution of his industry leading unified life science platforms together with his strategic life sciences customers.

About Ennov

Ennov provides the most intuitive, comprehensive, and cost-effective suite of software solutions for the life sciences industry. From leading pharmaceutical companies to emerging biotechnology companies, we proudly serve over 200 companies and 150,000 users around the world. Our solutions are designed and built to support the entire Life Sciences R&D continuum including Clinical, Regulatory, Quality, Pharmacovigilance and Commercial.  Ennov is headquartered in Paris and has offices in the US and UK. For more information about Ennov, please see www.ennov.com

About Boehringer Ingelheim

Family-owned since it was established in 1885, Boehringer Ingelheim is one of the pharmaceutical industry’s top 20 companies. Some 50,000 employees create value through innovation daily for the three business areas human pharmaceuticals, animal health and biopharmaceuticals. In 2017, Boehringer Ingelheim achieved net sales of nearly 18.1 billion euros. R&D expenditure, exceeding three billion euros, corresponded to 17.0 percent of net sales.

As a family-owned company, Boehringer Ingelheim plans in generations and focuses on long-term success. The company therefore aims at organic growth from its own resources with simultaneous openness to partnerships and strategic alliances in research. In everything it does, Boehringer Ingelheim naturally adopts responsibility towards mankind and the environment.

More information about Boehringer Ingelheim can be found on www.boehringer-ingelheim.com

Share :

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn

Register to access to our exclusive private library!